Last C$1.24 CAD
Change Today 0.00 / 0.00%
Volume 36.0K
BLU On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 3:53 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tony Matzouranis

Vice President of Business Development, BELLUS Health Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

41C$237,313
As of Fiscal Year 2013

Background*

Mr. Tony Matzouranis has been the Vice President of Business Development at BELLUS Health Inc. since February 21, 2012. Mr. Matzouranis joined Bellus in 2010 and oversees BELLUS Health ’s licensing and business development activities. He served as a Senior Director, Business Development at BELLUS Health Inc. from March 2010 to February 21, 2012. He has over 13 years of experience in structuring and building successful partnerships via in / out-licensing, mergers and ...

Read Full Background

Corporate Headquarters*

275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Canada

Phone: 450-680-4500
Fax: 450-680-4501

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Master's Degree
Universite Du Quebec

Other Affiliations*

Annual Compensation*

SalaryC$175,000
Total Annual CompensationC$175,000

Stock Options*

All Other CompensationC$20,750
Total Number of Options400,000

Total Compensation*

Total Annual Cash CompensationC$237,313
Total Short Term CompensationC$175,000
Other Long Term CompensationC$20,750
Total Calculated CompensationC$237,313
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLU:CN C$1.24 CAD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Robert H. Gundel Ph.D., M.B.A.Chief Executive Officer, President, Director and Member of Financing Committee
Amorfix Life Sciences Ltd.
C$283.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BELLUS HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.